Evan Rachlin is the Co-Founder and Managing Partner of Ascenta Capital, a biotech venture fund. His career combines high-level strategy and investment, with previous roles as a Managing Director at Blackstone Life Sciences, Head of Strategy at Moderna, and Principal at Bain Capital Ventures. He holds both an MD and an AB from Harvard University.
Evan demonstrates a strong commitment to pediatric healthcare through his role on the board of the Boston Childrens Hospital Trust. This philanthropic involvement reflects a dedication to advancing medical care and supporting community health initiatives beyond his direct investment work.
Unique fact: Evan graduated magna cum laude from Harvard with a degree in Biochemistry and Japanese before earning his MD.